Daiwa Securities Group
CNTB

Daiwa Securities Group’s Connect Biopharma Holdings CNTB Stock Holding History

Daiwa Securities Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,069
Closed -$147K – 1401
2021
Q3 		$147K Buy
+6,069
New +$137K ﹤0.01% 969

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Daiwa Securities Group's CNTB Position: Q4 2021 in Review

Daiwa Securities Group sold out of Connect Biopharma Holdings (CNTB) in Q4 2021, closing a stake of 6,069 shares — an estimated $147K sold.

Daiwa Securities Group first reported a position in CNTB in Q3 2021 and held it in 1 quarter. The position peaked at $147K in Q3 2021. 29 funds tracked by Wall St. Rank hold CNTB as of Q4 2021.

  • Daiwa Securities Group reported no remaining Connect Biopharma Holdings position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 6,069 Connect Biopharma Holdings shares in Q4 2021, an estimated $147K.
  • Daiwa Securities Group first reported a position in Connect Biopharma Holdings in Q3 2021 and held it in 1 quarter.
  • Daiwa Securities Group's Connect Biopharma Holdings position peaked at $147K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.